Pregled bibliografske jedinice broj: 710679
A376S in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Increased Risk of Virological Failure to Nevirapine Therapy
A376S in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Increased Risk of Virological Failure to Nevirapine Therapy // The Journal of infectious diseases, 204 (2011), 5; 741-752 doi:10.1093/infdis/jir385 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 710679 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
A376S in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Increased Risk of Virological Failure to Nevirapine Therapy
Autori
Paredes, R. ; ... ; Begovac, Josip ; ...
Izvornik
The Journal of infectious diseases (0022-1899) 204
(2011), 5;
741-752
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Benzoxazines/pharmacology/therapeutic use; Drug Resistance; Viral/ genetics; Female; Genotype; HIV Infections/ drug therapy/virology; HIV Reverse Transcriptase/ genetics; HIV-1/drug effects/enzymology/ genetics; Humans; Male; Middle Aged; Models; Molecular; Mutation; Nevirapine/pharmacology/ therapeutic use; Protein Structure; Tertiary; Reverse Transcriptase Inhibitors/pharmacology/ therapeutic use; Risk Factors; Treatment Failure; Viral Load
Sažetak
The clinical relevance of mutations in the connection subdomain and the ribonuclease (RNase) H domain of HIV-1 reverse transcriptase (RT) is uncertain. The risk of virological failure to nonnucleoside RT inhibitor (NNRTI)-based antiretroviral therapy (ART) was evaluated in NNRTI-naive patients who started NNRTIs in the EuroSIDA study after July 1997 according to preexisting substitutions in the connection subdomain and the RNase H domain of HIV-1 RT. An observed association between A376S and virological failure was further investigated by testing in vitro NNRTI susceptibility of single site-directed mutants and patient-derived recombinant viruses. Enzymatic assays also determined the effects of A376S on nevirapine and template-primer binding to HIV-1 RT. Virological failure occurred in 142 of 287 (49%) individuals: 77 receiving nevirapine (67%) and 65 receiving efavirenz (38%) (P < .001). Preexisting A376S was associated with an increased risk of virological failure to nevirapine (relative hazard [RH] = 10.4 ; 95% confidence interval [CI], 2.0- 54.7), but it did not affect efavirenz outcome the same way (RH = 0.5 ; 95% CI, 0.1-2.2) (P value for interaction = .013). A376S conferred selective low-level nevirapine resistance in vitro, and led to greater affinity for double-stranded DNA. The A376S substitution in the connection subdomain of HIV-1 RT causes selective nevirapine resistance and confers an increased risk of virological failure to nevirapine-based ART.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Napomena
Group Authors: EuroSIDA.
POVEZANOST RADA
Projekti:
108-1080116-0098 - Epidemiološka i klinička obilježja zaraze HIV-om u Hrvatskoj (Begovac, Josip, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Profili:
Josip Begovac
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE